Cefritec TZ 250mg/31.25mg Injection
Marketer
Smotec Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefritec TZ 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial for optimal efficacy. Premature cessation can compromise treatment effectiveness; complete the full course even with symptom improvement. Common adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea, indigestion). Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) require urgent medical help. Inform your doctor of all current medications, including those for pre-existing conditions, before initiating treatment. Pregnant or lactating individuals must consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are essential for recovery. Your physician may order lab tests to monitor treatment response.
Primary Ingredients of Cefritec TZ 250mg/31.25mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Cefritec TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefritec TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Cefritec TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefritec TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified assistant. Self-medication is strongly discouraged.
How Cefritec TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefritec TZ 250mg/31.25mg Injection, offer a targeted antibiotic approach. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefritec TZ 250mg/31.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefritec TZ 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
The administration of Cefritec TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefritec TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefritec TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Cefritec TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dosage of Cefritec TZ 250mg/31.25mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefritec TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Cefritec TZ 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Cefritec TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently